Releases
Found 37332 articles
TXNM Energy Prices $400 Million Common Stock Offering
Albuquerque-based TXNM Energy is tapping capital markets with a public offering of 7,079,646 shares priced at $56.50 each. The utility holding company expects to generate approximately $400 million in gross proceeds, which the firm plans to direct toward the full repayment of an outstanding term loan.
Baidu Shifts to Dual-Primary Listing on Hong Kong Stock Exchange
Baidu officially transitioned its secondary listing status to a dual-primary listing on the Main Board of the Hong Kong Stock Exchange today. This strategic shift places the Chinese AI giant on equal regulatory footing in Hong Kong and the United States, where it maintains its presence on the Nasdaq Global Select Market.
Ecopetrol Reshuffles Senior Leadership in Innovation and Energy Divisions
Colombia's state-controlled energy giant Ecopetrol announced a series of executive leadership changes on August 31, 2026, affecting its science, technology, and energy transition departments. The board’s latest resolutions mark a transition for both the corporate vice presidency of innovation and the executive vice presidency of energy transition.
Investors Scrutinize Elauwit Connection Following Revenue Discrepancies
A 6.8% drop in Elauwit Connection’s stock price has triggered a formal investigation by the Rosen Law Firm. The legal action centers on allegations that the company released misleading business information, specifically concerning revenue recognition errors identified in its 2025 interim financial filings.
Rosen Law Firm Probes Disc Medicine Over Misleading Disclosure Claims
A 22 percent plunge in Disc Medicine shares following a February regulatory setback has triggered a formal investigation by the Rosen Law Firm. Attorneys are now vetting potential securities claims, alleging the company provided investors with materially misleading information regarding its bitopertin drug development program.
XTI Aerospace Faces Nasdaq Delisting Risk Over Delayed Filing
XTI Aerospace has received a formal deficiency notice from Nasdaq after failing to file its second-quarter financial report on time. The delay stems from an ongoing internal review involving the company’s former CEO, who resigned abruptly on August 17, leaving the firm’s regulatory standing in a state of uncertainty.
Rosen Law Firm Investigates Flow Foundation Over Misleading Claims
Investors who held FLOW cryptocurrency between December 27 and December 29, 2025, are being recruited for a potential class action lawsuit. New York-based Rosen Law Firm claims the Flow Foundation may have released materially misleading business information, prompting a formal investigation into potential securities law violations and investor losses.
AAN and AHS Release Updated Migraine Prevention Guidelines
The American Academy of Neurology and the American Headache Society have issued a joint clinical update, replacing their 2012 standards to reflect a decade of research. The new guidance provides evidence-based recommendations for both episodic and chronic migraine, incorporating modern therapies alongside established pharmacological treatments for adult patients.
Investors Eye Lead Role in Securities Fraud Suit Against Pentwater Capital
Investors who purchased Avis Budget Group securities between February 20, 2025, and April 21, 2026, face a September 29 deadline to seek lead plaintiff status in a class action lawsuit. The litigation targets Pentwater Capital Management LP over allegations of market manipulation and orchestrating a massive short squeeze.
Bloom Energy Investors Face September Deadline in Securities Lawsuit
Investors who purchased Bloom Energy Corporation securities between February 27, 2025, and July 8, 2026, have until September 28, 2026, to file as lead plaintiffs in an ongoing class action lawsuit alleging the company misled shareholders regarding its supply chain and reliance on Chinese scandium.
Solidion Technology Expands Board with Three Financial Experts
Solidion Technology has appointed Kimi L. Ellen, Mark N. Schwartz, and Dante W. Robinson to its board of directors, effective August 31. The move expands the battery technology provider’s oversight team to seven members, with a majority now qualifying as independent under Nasdaq listing standards.
Genomma Lab Secures MXN 1 Billion Credit Facility from Banamex
Mexico City-based Genomma Lab Internacional has finalized a three-year, MXN 1 billion credit facility with Banamex to restructure its balance sheet. The pharmaceutical firm intends to use the capital to prepay existing bank loans and address upcoming maturities of its outstanding certificates, effectively optimizing its long-term debt profile.
Three Lions Acquisition Corp. Prices $100 Million Nasdaq IPO
Three Lions Acquisition Corp. has priced its initial public offering at $100 million, launching 10 million units at $10.00 each. The blank check company, which targets growth within the sports, hospitality, and real estate sectors, plans to begin trading on the Nasdaq Global Market under the ticker TLACU starting September 1.
Mixx Technologies Targets AI Inference Bottlenecks with SxC Connector
San Jose-based Mixx Technologies has unveiled the SxC Connector, a high-density optical interface capable of terminating 24,576 fibers in a single rack unit. Designed to address the scaling demands of hyperscale AI infrastructure, the hardware enables multi-petabit connectivity by streamlining both front-plane and back-plane optical integration.
Investors Eye Class Action Against UP Fintech Holding Limited
Shares of UP Fintech Holding Limited plummeted 25.3% on May 22, 2026, after Chinese regulators announced a sweeping crackdown on online brokers operating without local licenses. The market volatility, which followed reports of illegal cross-border securities activity, has triggered a new investigation by the Rosen Law Firm into potential investor losses.
Global PTFE Membranes Market Projected to Reach $2.84 Billion by 2031
The global market for polytetrafluoroethylene (PTFE) membranes is set for steady expansion, with valuations expected to climb from $2.14 billion in 2026 to $2.84 billion by 2031. Driven by a 5.8% compound annual growth rate, the sector is increasingly vital to pharmaceutical, semiconductor, and industrial filtration applications.
UWM Holdings Investors Face October Deadline for Class Action Suit
Investors who purchased UWM Holdings Corporation securities between March 9 and August 5, 2026, have until October 13 to seek lead plaintiff status in a federal class action lawsuit. The litigation follows a sharp 35% drop in share price triggered by substantial losses linked to failed hedging strategies.
Enliven Therapeutics to Present ELVN-001 Clinical Data at SOHO 2026
Enliven Therapeutics will showcase updated findings from its Phase 1 ENABLE trial during the Society of Hematologic Oncology annual meeting in Houston this September. The company plans to present both an oral report and a poster session detailing the performance of its lead candidate, ELVN-001, in treating chronic myeloid leukemia.
Ultra Violette Debuts First FDA-Approved Bemotrizinol Sunscreen in US
After a quarter-century of regulatory stagnation, the US suncare market is evolving. Australian brand Ultra Violette has introduced Unblock Screen SPF 50, marking the first time a product containing the broad-spectrum filter Bemotrizinol—recently cleared by the FDA—has reached American consumers.
Astellas Strikes Pricing Agreement with U.S. Government
Astellas Pharma has committed to lowering medicine prices within the Medicaid program as part of a new voluntary pact with the U.S. government. The agreement aims to balance corporate innovation with patient affordability, while also bolstering the nation’s emergency supply of critical transplant medication.
ActivatedYou’s Essential Skin Food Named Collagen Product of the Year
The wellness brand ActivatedYou has secured the 2026 Mindful Award for Collagen Product of the Year, distinguishing its Essential Skin Food supplement in a competitive beauty market. The recognition highlights the brand’s shift away from animal-derived ingredients in favor of a plant-based formula designed to stimulate the body’s own collagen production.
Kazia Therapeutics Secures $40 Million in Oversubscribed Public Offering
Sydney-based Kazia Therapeutics has closed an oversubscribed public offering, securing $40 million in upfront gross proceeds to accelerate the clinical development of its oncology pipeline. The deal includes milestone-linked warrants that could push the total potential capital injection to $120 million, contingent on future breast cancer data readouts.
Why Data Governance Fails When Companies Buy Tools Before Strategy
Organizations are pouring capital into AI and data management tools, yet many remain trapped in a cycle of fragmented decision-making. According to Info-Tech Research Group, businesses often prioritize software catalogs and glossaries over the fundamental human judgments required to define data authority, creating significant activity without achieving any measurable business impact.
Investors Seek Lead Plaintiff Status in Taboola Securities Fraud Suit
Investors who incurred financial losses holding Taboola.com Ltd. stock between May 6 and August 4, 2026, face an October 20 deadline to petition the court for lead plaintiff status. The move follows a class action complaint alleging the company obscured critical details regarding the quality of its publisher network.
Jack Henry Reports Cybersecurity Breach via Vishing Attack
A voice phishing scheme targeted Jack Henry & Associates, resulting in a data breach within the company’s internal non-production environment. While the firm confirmed that fewer than 10 clients had their personally identifiable information exposed, the incident triggered an extortion attempt that the company ultimately rejected.
Sealaska Bridges Indigenous Heritage and Global Ocean Conservation
Fifty years after the Alaska Native Claims Settlement Act reshaped regional governance, Sealaska is leveraging a global portfolio of ocean health businesses to fund cultural preservation and environmental stewardship. The corporation balances for-profit enterprise with the ancestral responsibilities of its Tlingit, Haida, and Tsimshian shareholders.
Chicago Auto Show Expands Test Drive Event Beyond Electric Vehicles
The Chicago Automobile Trade Association is rebranding its fall automotive event to include gas-powered and hybrid models alongside electric vehicles. Formerly known as Chicago Drives Electric, the four-day program, titled Chicago Auto Show: Behind the Wheel, will offer hands-on test drives starting October 1 at the ComEd Building in Oakbrook Terrace.
GABA Therapeutics Sets Date for 2026 Annual Stockholder Meeting
GABA Therapeutics has officially scheduled its 2026 Annual Meeting of Stockholders for September 10, 2026, at 9:30 a.m. Pacific Time. The proceedings will take place at the company's offices located at 5000 Birch Street, West Tower, Suite 3000, in Newport Beach, California, to address the election of company directors.
Aardvark Therapeutics Faces Investor Lawsuit Over Drug Safety Claims
Investors who incurred financial losses holding Aardvark Therapeutics, Inc. stock now have until October 13, 2026, to apply for lead plaintiff status in a securities fraud class action. The litigation, spearheaded by Glancy Prongay Wolke & Rotter LLP, targets alleged misrepresentations regarding the safety and commercial viability of the company’s lead drug candidate, ARD-101.
Investors Eye Lead Plaintiff Role in Hertz Securities Fraud Lawsuit
Investors who lost more than $100,000 in Hertz Global Holdings stock are facing a September 22, 2026, deadline to seek lead plaintiff status in a pending securities fraud class action. The lawsuit targets alleged misrepresentations regarding the company’s liquidity and the health of the used-car market during the spring of 2026.